123 related articles for article (PubMed ID: 8773161)
1. Steady-state plasma concentrations of midazolam in critically ill infants and children.
Hughes J; Gill AM; Mulhearn H; Powell E; Choonara I
Ann Pharmacother; 1996 Jan; 30(1):27-30. PubMed ID: 8773161
[TBL] [Abstract][Full Text] [Related]
2. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
Gupta P; Whiteside W; Sabati A; Tesoro TM; Gossett JM; Tobias JD; Roth SJ
Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of midazolam in critically ill pediatric patients.
Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of interrupted versus continuous sedative infusions in ventilated children.
Gupta K; Gupta VK; Jayashree M; Singhi S
Pediatr Crit Care Med; 2012 Mar; 13(2):131-5. PubMed ID: 21283046
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.
Vet NJ; Brussee JM; de Hoog M; Mooij MG; Verlaat CW; Jerchel IS; van Schaik RH; Koch BC; Tibboel D; Knibbe CA; de Wildt SN;
Am J Respir Crit Care Med; 2016 Jul; 194(1):58-66. PubMed ID: 26796541
[TBL] [Abstract][Full Text] [Related]
7. The effect of critical illness and inflammation on midazolam therapy in children.
Vet NJ; de Hoog M; Tibboel D; de Wildt SN
Pediatr Crit Care Med; 2012 Jan; 13(1):e48-50. PubMed ID: 21057365
[TBL] [Abstract][Full Text] [Related]
8. Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years.
Ince I; de Wildt SN; Peeters MY; Murry DJ; Tibboel D; Danhof M; Knibbe CA
Ther Drug Monit; 2012 Aug; 34(4):381-9. PubMed ID: 22660604
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of exogenous epinephrine in critically ill children.
Fisher DG; Schwartz PH; Davis AL
Crit Care Med; 1993 Jan; 21(1):111-7. PubMed ID: 8420716
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
[TBL] [Abstract][Full Text] [Related]
11. Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis.
Kos MK; Miksić M; Jovanović M; Roškar R; Grosek Š; Grabnar I
Eur J Pharm Sci; 2020 Jan; 141():105095. PubMed ID: 31626965
[TBL] [Abstract][Full Text] [Related]
12. [Continuous infusion of ketamine and midazolam for prolonged sedation in the intensive care unit].
Kawamata M; Ujike Y; Miyabe M; Kobayashi I; Arakawa J; Namiki A; Imaizumi H; Yamaya K
Masui; 1991 Dec; 40(12):1793-8. PubMed ID: 1770572
[TBL] [Abstract][Full Text] [Related]
13. Short-term propofol infusion as an adjunct to extubation in burned children.
Sheridan RL; Keaney T; Stoddard F; Enfanto R; Kadillack P; Breault L
J Burn Care Rehabil; 2003; 24(6):356-60. PubMed ID: 14610418
[TBL] [Abstract][Full Text] [Related]
14. Age-related amrinone pharmacokinetics in a pediatric population.
Allen-Webb EM; Ross MP; Pappas JB; McGough EC; Banner W
Crit Care Med; 1994 Jun; 22(6):1016-24. PubMed ID: 8205809
[TBL] [Abstract][Full Text] [Related]
15. Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children.
Allen E; Pettigrew A; Frank D; Thompson S; Myers C; Yamashita T; Blumer JL
Crit Care Med; 1997 Jan; 25(1):181-9. PubMed ID: 8989196
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of continuous infusions of fentanyl in critically ill children.
Katz R; Kelly HW
Crit Care Med; 1993 Jul; 21(7):995-1000. PubMed ID: 8319480
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
Malacrida R; Fritz ME; Suter PM; Crevoisier C
Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.
Jacqz-Aigrain E; Daoud P; Burtin P; Maherzi S; Beaufils F
Eur J Clin Pharmacol; 1992; 42(3):329-32. PubMed ID: 1577053
[TBL] [Abstract][Full Text] [Related]
20. Age is of influence on midazolam requirements in a paediatric intensive care unit.
de Gast-Bakker DA; van der Werff SD; Sibarani-Ponsen R; Swart EL; Plötz FB
Acta Paediatr; 2007 Mar; 96(3):414-7. PubMed ID: 17407468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
